1 / 12

STUDY DESIGN FOR DIAGNOSTIC STUDY FOR MELIOIDOSIS

STUDY DESIGN FOR DIAGNOSTIC STUDY FOR MELIOIDOSIS. Dr Direk Limmathurotsakul, MD MSc PhD. Introduction: 3 phases of study design. Laboratory phase - develop test - test with few cases and healthy controls - prove of concept. Case-control phase

neil-mercer
Télécharger la présentation

STUDY DESIGN FOR DIAGNOSTIC STUDY FOR MELIOIDOSIS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. STUDY DESIGN FOR DIAGNOSTIC STUDY FOR MELIOIDOSIS Dr Direk Limmathurotsakul, MD MSc PhD

  2. Introduction: 3 phases of study design Laboratory phase - develop test - test with few cases and healthy controls - prove of concept Case-control phase - test with definite cases and definite controls - calculate Se & Sp Prospective phase - test with disease-suspected patients - calculate Se, Sp, PPV & NPV

  3. Introduction: 3 phases of study design Laboratory phase - develop test - test with few cases and healthy controls - prove of concept Case-control phase - test with definite cases and definite controls - calculate Se & Sp Prospective phase - test with disease-suspected patients - calculate Se, Sp, PPV & NPV Look promising

  4. Introduction: 3 phases of study design Laboratory phase - develop test - test with few cases and healthy controls - prove of concept Case-control phase - test with definite cases and definite controls - calculate Se & Sp Prospective phase - test with disease-suspected patients - calculate Se, Sp, PPV & NPV Look promising Look good

  5. Introduction: 3 phases of study design Laboratory phase - develop test - test with few cases and healthy controls - prove of concept Case-control phase - test with definite cases and definite controls - calculate Se & Sp Prospective phase - test with disease-suspected patients - calculate Se, Sp, PPV & NPV Look promising Look good Look rubbish (GS problem)

  6. Good guideline

  7. Good guideline • Recommendation 1: Access index test’s ability to predict patient-relevant outcomes instead of test accuracy • Recommendation 2: Access the concordance of difference tests instead of test accuracy • Recommendation 3: Qualify the interpretation of “naïve” estimates of the index test’s performance • Recommendation 4: Imperfect gold standard model

  8. Recommended design for melioidosis • Define need For example, estimate Se, Sp, PPV and NPV in a prospective design (to represent the real clinical situation) • Define study population (that we would like to infer the estimated accuracy to) • Next: select reference standard

  9. Recommended design for melioidosis • If there are more than one population, at least 2 diagnostic tests (3 tests are preferred) Those 2 tests should be based on 2 different biological mechanism (e.g. one antigen detection [culture] and one antibody detection [IHA]) • If there is only one population, at least 3 diagnostic tests (5 tests are preferred) Those 3 tests should be based on 3 different biological mechanism (e.g. one antigen detection [culture / PCR assays], one antibody detection [IHA/ELISA], one clinical detection [ultrasonogram/CT scan])

  10. Recommended design for melioidosis • Consider repeated sampling and convalescent specimens • Day 4 and Day 7 specimens may have clinical implication for changing the diagnosis and treatment • Day 14 and Day 28 specimens may have clinical implication for starting oral treatment regimen • Consider long-term outcome for relapse/recurrent infection • Four-fold rising is arbitrary and based on imperfect gold standard. This should be evaluated with better approach • Adequate sample size is required (enough diseased patients for sensitivity estimation is important than the total number)

  11. Recommended design for melioidosis • Select sites • Appoint study team • Train staff • Provide GCP • Conduct QC and monitoring • Collect data • Perform analysis • Report results using STARD checklist • Disseminate results

  12. END

More Related